NASDAQ:CYCC Cyclacel Pharmaceuticals (CYCC) News Today $0.64 -0.01 (-2.15%) (As of 12:58 PM ET) Add Compare Share Share Today's Range$0.64▼$0.6750-Day Range$0.52▼$0.7052-Week Range$0.50▼$2.41Volume10,360 shsAverage Volume64,140 shsMarket Capitalization$8.03 millionP/E RatioN/ADividend YieldN/APrice Target$8.00 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Get Cyclacel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CYCC and its competitors with MarketBeat's FREE daily newsletter. Email Address CYCC Media Mentions By Week CYCC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYCC News Sentiment▼0.000.49▲Average Medical News Sentiment CYCC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYCC Articles This Week▼10▲CYCC Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by Analysts at StockNews.comamericanbankingnews.com - June 2 at 4:48 AMCyclacel Pharmaceuticals (NASDAQ:CYCC) Earns Sell Rating from Analysts at StockNews.comamericanbankingnews.com - May 26 at 3:58 AMOppenheimer Maintains Cyclacel Pharmaceuticals (CYCC) Outperform Recommendationmsn.com - May 26 at 3:44 AMHead-To-Head Survey: Cyclacel Pharmaceuticals (NASDAQ:CYCC) versus Aldeyra Therapeutics (NASDAQ:ALDX)americanbankingnews.com - May 20 at 2:46 AMQ4 2023 Earnings Forecast for Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Issued By Brookline Capital Managementamericanbankingnews.com - May 16 at 4:20 AMCyclacel Pharmaceuticals (NASDAQ:CYCC) Research Coverage Started at StockNews.comamericanbankingnews.com - May 9 at 6:44 AMCyclacel Pharmaceuticals Announces Receipt of $4.7 Million R&D Tax Creditfinance.yahoo.com - May 3 at 10:29 AMCyclacel Pharmaceuticals (NASDAQ:CYCC) Receives New Coverage from Analysts at StockNews.comamericanbankingnews.com - May 1 at 5:48 AMStockNews.com Initiates Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC)americanbankingnews.com - April 23 at 5:46 AMCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - March 8 at 11:56 PMOppenheimer Maintains Outperform Rating for Cyclacel Pharmaceuticals: Here's What You Need To Knowmsn.com - March 7 at 4:36 PMA Preview Of Cyclacel Pharmaceuticals's Earningsmsn.com - March 3 at 3:29 PMCyclacel Pharmaceuticals to Participate in the 2023 BIO CEO & Investor Conferencefinance.yahoo.com - January 30 at 10:58 AMCyclacel Pharmaceuticals to Present at Biotech Showcase and Participate in a Corporate Access Event During the J.P. Morgan Healthcare Conference in January 2023finance.yahoo.com - December 15 at 12:47 PMCyclacel Pharmaceuticals, Inc. (CYCC) Q3 2022 Earnings Call Transcriptseekingalpha.com - November 9 at 8:56 PMEarnings Outlook For Cyclacel Pharmaceuticalsmsn.com - November 8 at 4:16 PMHere's What to Expect Ahead of Wix's (WIX) Q3 Earnings Releasefinance.yahoo.com - November 7 at 1:43 PMCyclacel Reports Preliminary Data From Its Phase 1/2 Clinical Trial of Oral Fadraciclib in Patients With Solid Tumors and Lymphoma at ENA 2022finance.yahoo.com - October 26 at 11:37 AMCyclacel Pharmaceuticals (NASDAQ: CYCC)fool.com - October 14 at 5:10 PMCyclacel Pharmaceuticals To Present Preliminary Data From The Phase 1/2 Clinical Trial Of Oral Fadraciclib At The 34th EORTC-NCI-AACR Symposiumfinance.yahoo.com - October 13 at 9:50 AMCyclacel stock rises 16% as net loss narrows, income growsseekingalpha.com - August 11 at 5:56 PMCyclacel To Test Higher Doses Of Fadraciclib In Solid Tumor Patientsfinance.yahoo.com - June 30 at 4:39 PMCyclacel Pharmaceuticals Achieves Key Business Objectives in First Half of 2022 and Continues to Advance Clinical Pipelinefinance.yahoo.com - June 30 at 11:39 AMCyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q1 2022 Results - Earnings Call Transcriptseekingalpha.com - May 11 at 9:13 PMCyclacel Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - May 11 at 4:13 PMCyclacel Pharmaceuticals's Earnings Outlookbenzinga.com - May 10 at 1:51 PMCyclacel Pharmaceuticals to Release First Quarter 2022 Financial Resultsfinance.yahoo.com - May 4 at 10:09 AMCyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Cyc140 in Patients With Advanced Solid Tumors and Lymphomasfinance.yahoo.com - April 19 at 12:05 PMCyclacel Pharmaceuticals jumps on preclinical data for blood cancer treatment fadraciclibseekingalpha.com - April 12 at 9:30 AMCyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Resultsfinance.yahoo.com - March 28 at 5:53 PMCyclacel Pharmaceuticals Q4 2021 Earnings Previewseekingalpha.com - March 25 at 6:20 PMCyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2021 Financial Resultsfinance.yahoo.com - March 22 at 7:53 AMCyclacel Pharmaceuticals to Present at the 32nd Annual Oppenheimer Healthcare Conferencefinance.yahoo.com - March 9 at 7:49 AMCyclacel Pharmaceuticals, Inc. (CYCC)finance.yahoo.com - February 26 at 8:18 PMCyclacel Pharmaceuticals reveals plans for cancer drug programs for 2022seekingalpha.com - January 6 at 1:16 PMCyclacel Pharmaceuticals Reviews 2021 Achievements And Announces Key Business Objectives for 2022finance.yahoo.com - January 6 at 8:13 AMCyclacel Pharmaceuticals to Participate in Biotech Showcase 2022 Virtual Conferencefinance.yahoo.com - December 23 at 8:01 AMVow ASA: Vow bags USD 5.2 million cruise retrofit contractfinance.yahoo.com - December 7 at 8:44 AMCyclacel Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Business Updatefinance.yahoo.com - October 29 at 8:02 AMCyclacel Pharmaceuticals Presenting at Three Conferences in Septemberfinance.yahoo.com - September 8 at 8:14 AMCyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q2 2021 Results - Earnings Call Transcriptseekingalpha.com - August 12 at 6:22 PMCyclacel Pharmaceuticals, Inc. Common Stock (CYCC)nasdaq.com - August 10 at 10:21 PMCyclacel Pharmaceuticals to Release Second Quarter 2021 Financial Results and Provide Business Updatefinance.yahoo.com - August 3 at 7:13 AMCyclacel Pharmaceuticals Convertible Exchangeable Preferred Stock About To Put More Money In Your Pocketnasdaq.com - July 13 at 2:37 PMCyclacel Pharmaceuticals to Present at Ladenburg Thalmann’s Virtual 2021 Healthcare Conferencefinance.yahoo.com - July 7 at 7:59 AMBenzinga Insightsbenzinga.com - June 6 at 6:04 PMChecking In On Cyclacel Pharmaceuticalsseekingalpha.com - April 7 at 5:46 PMCyclacel Pharmaceuticals Announces Closing of $14.5 Million Underwritten Public Offering and ...apnews.com - March 17 at 7:32 AMCyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stockfinance.yahoo.com - March 11 at 6:15 PMCyclacel Pharmaceuticals (NASDAQ:CYCC) Downgraded by Zacks Investment Research to Sellmarketbeat.com - February 26 at 7:47 PM Get Cyclacel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CYCC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Guardion Health Sciences News Today AcelRx Pharmaceuticals News Today Can-Fite BioPharma News Today Adial Pharmaceuticals News Today Diffusion Pharmaceuticals News Today Galmed Pharmaceuticals News Today Catalyst Biosciences News Today ZyVersa Therapeutics News Today RedHill Biopharma News Today Avenue Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:CYCC) was last updated on 6/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.